指南与共识主动脉疾病

钝性胸主动脉损伤管理系统综述:支持SVS临床实践指南制定

A systematic review supporting the development of the Society for Vascular Surgery Clinical Practice Guidelines on the management of blunt thoracic aortic injury.
指南 / 共识 · J Vasc Surg · 2025-06-06

本系统综述由血管外科学会写作委员会委托,检索多个数据库,纳入21项研究,评估钝性胸主动脉损伤评估与管理的七个关键问题,采用GRADE方法评价证据确定性。结果显示证据基础有限且不确定性高,证据提示条件允许时延迟干预可能获益,尤其对合并损伤患者;低级别损伤非手术治疗可能合适,干预时机和术中抗凝使用可能是TEVAR结局的重要相关因素。

要点

  • Grade 1和2损伤中,TEVAR与非手术治疗相比主动脉相关死亡率更高(RR 8.11,95%CI 1.25-52.57)。
  • 早期(<24小时)TEVAR较延迟(>24小时)干预死亡率更高(RR 2.04,95%CI 1.45-2.86),证据确定性中等。
  • 合并创伤性脑损伤患者中,早期TEVAR(<9小时)较延迟修复死亡率更高(12.9% vs 6.5%,P=.003),证据确定性低。

核心结论

  • 本系统综述显示证据基础有限且许多患者重要结局不确定性高。
  • 证据提示条件允许时延迟干预可能获益,尤其对合并损伤患者。
  • 低级别损伤非手术治疗可能合适,干预时机和术中抗凝使用可能是TEVAR结局的重要相关因素。

研究设计与样本

  • 由血管外科学会写作委员会委托的系统综述,检索MEDLINE、EMBASE、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews和Scopus。
  • 由成对独立评审者选择和评价针对血管外科学会委员会提出的七个关键问题的研究,共纳入21项研究。
  • 采用GRADE方法评估证据确定性。

主要发现

  • Grade 1和2损伤中,TEVAR与非手术治疗相比主动脉相关死亡率更高(RR 8.11,95%CI 1.25-52.57)。
  • 早期(<24小时)TEVAR较延迟(>24小时)干预死亡率更高(RR 2.04,95%CI 1.45-2.86),证据确定性中等。
  • 左锁骨下动脉覆盖且未血运重建时缺血事件可能增加,证据确定性低。
  • TEVAR术中肝素使用与较低死亡率相关(RR 0.41,95%CI 0.23-0.71),证据确定性低。
  • 合并创伤性脑损伤患者中,早期TEVAR(<9小时)较延迟修复死亡率更高(12.9% vs 6.5%,P=.003),证据确定性低。

关键数值与推荐

  • Grade 1和2损伤:TEVAR vs 非手术治疗,主动脉相关死亡率RR 8.11(95%CI 1.25-52.57)。
  • 早期(<24小时)TEVAR vs 延迟(>24小时)干预,死亡率RR 2.04(95%CI 1.45-2.86),证据确定性中等。
  • TEVAR术中肝素使用 vs 未使用,死亡率RR 0.41(95%CI 0.23-0.71),证据确定性低。
  • 合并创伤性脑损伤:早期TEVAR(<9小时)死亡率12.9% vs 延迟修复6.5%(P=.003),证据确定性低。
  • Grade 2损伤非手术治疗:多数损伤在8周内消退,中期结局良好。

临床怎么用

  • 证据提示条件允许时延迟干预可能获益,尤其对合并损伤患者。
  • 低级别损伤非手术治疗可能合适。
  • 干预时机和术中抗凝使用可能是TEVAR结局的重要相关因素。
  • 这些证据合成结果连同患者个体因素和地方专长将用于指导临床实践指南制定。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The writing committee from the Society for Vascular Surgery has commissioned this systematic review to support the development of clinical practice guidelines on the management of patients with blunt thoracic aortic injury. METHODS: We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus. Pairs of independent reviewers selected and appraised studies addressing seven key questions identified by the Society for Vascular Surgery committee regarding the evaluation and management of patients with blunt thoracic aortic injury. The certainty of evidence was assessed using the GRADE approach. RESULTS: We included 21 studies across seven key clinical questions. For Grade 1 and 2 injuries, thoracic endovascular aortic repair (TEVAR) was associated with higher aortic-related mortality compared with nonoperative management (relative risk [RR], 8.11; 95% confidence interval [CI], 1.25-52.57. Early (<24 hours) TEVAR was associated with higher mortality compared with delayed (>24 hours) intervention (RR, 2.04; 95% CI, 1.45-2.86) with moderate certainty of evidence. There may be an increase in ischemic events when the left subclavian artery is covered and not revascularized, with low certainty of evidence. Intraoperative heparin use during TEVAR was associated with lower mortality (RR, 0.41; 95% CI, 0.23-0.71) with low certainty of evidence. In patients with concurrent traumatic brain injury, early TEVAR (<9 hours) was associated with higher mortality (12.9% vs 6.5%; P = .003) compared with delayed repair with low certainty of evidence. Analysis of imaging surveillance protocols suggested potential benefits of systematic follow-up. For Grade 2 injuries managed nonoperatively, studies demonstrated favorable intermediate-term outcomes with most injuries resolving within 8 weeks. CONCLUSIONS: This systematic review demonstrates a limited evidence base with high uncertainty for numerous patient-important outcomes. The evidence suggests benefits of delayed intervention when feasible, particularly for patients with concurrent injuries. Nonoperative management may be appropriate for lower-grade injuries, whereas the timing of intervention and use of intraoperative anticoagulation may be important factors associated with outcomes in TEVAR. These findings of this evidence synthesis, along with individual patient factors and local expertise, will inform the development of clinical practice guidelines.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Firwana M, Seisa M, Farah M, et al. A systematic review supporting the development of the Society for Vascular Surgery Clinical Practice Guidelines on the management of blunt thoracic aortic injury. J Vasc Surg. 2025. PMID: 40482894. doi:10.1016/j.jvs.2025.05.208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。